FDA warns about lack of research, possible risks of CBD


2019-11-27 06:09:29 CNBC


CBD might not be as safe as the companies selling it say it is, the Food and Drug Administration is warning consumers. The cannabis compound has been widely touted as a harmless way to treat a slew of ailments, such as anxiety, pain and possibly even cancer — without much evidence to back it up. CBD products flooded the market this year after Congress legalized hemp last December. "We remain concerned that some people wrongly think that the myriad of CBD products on the market, many of which are illegal, have been evaluated by the FDA and determined to be safe, or that trying CBD 'can't hurt,'" FDA Principal Deputy Commissioner Amy Abernethy said in a statement Monday. Abernethy leads a working group at the FDA tasked with crafting regulations to bring legal CBD products to market. The FDA is under intense pressure from the public, as well as lawmakers like Senate Majority Leader Mitch McConnell, to come up with a solution. There are still "a number of question regarding CBD's safety – including reports of products containing contaminants, such as pesticides and heavy metals – and there are real risks that need to be considered," Abernethy said. Companies are adding CBD to creams, oils, food and beverages. However, it's currently illegal for companies to sell CBD-infused food and beverages across state lines and to market any CBD products with health claims the FDA has not evaluated. The FDA said it "has seen only limited data about CBD safety and these data point to real risks that need to be considered before taking CBD for any reason." The agency lays out possible risks of using CBD, such as liver injury, drug interactions and possibly even negative affects on male reproductive health. " In addition to the health risks CBD itself may pose, the FDA cautioned consumers to be aware of product quality. The industry is largely unregulated. The FDA said it has tested the chemical content of CBD in some products and found "many" did not contain the amount of CBD they said they did. The agency is also investigating reports of CBD containing "unsafe" levels of contaminants, such as pesticides, heavy metals and THC. The FDA on Monday also issued warning letters to 15 privately owned CBD companies for illegally advertising their products as treating diseases, selling products as dietary supplements and adding CBD to human and animal foods.
美国食品和药物管理局( FoodandDrugAdministration )警告消费者, CBD 可能不像销售公司所说的那样安全。 大麻化合物被广泛宣传为治疗一系列疾病的无害方法,如焦虑、疼痛,甚至癌症——没有太多证据支持它。国会去年12月将大麻合法化后, CBD 产品今年充斥市场。 “我们仍然担心一些人错误地认为市场上的大量生物多样性公约产品,其中许多是非法的,已经被 FDA 评估,并确定是安全的,或尝试生物多样性公约不能伤害,”美国食品和药物管理局首席副专员艾米·阿本尼在周一的一份声明中说。 Abernethy 领导了 FDA 的一个工作组,负责制定法规,将合法的 CBD 产品推向市场。FDA 正面临来自公众以及参议院多数党领袖麦康奈尔( MitchMcConnell )等议员的强烈压力,要求他们提出解决方案。 Abernethy 说,仍然存在“关于生物多样性公约的安全性的一些问题——包括含有污染物的产品的报告,如杀虫剂和重金属——还有一些真正的风险需要考虑。” 公司正在将 CBD 添加到奶油、油、食品和饮料中。然而,目前公司在州范围内销售 CBD 输液食品和饮料以及销售任何 CBD 产品的行为都是违法的, FDA 尚未对其进行评估。 FDA 说,它“只看到了有限的关于 CBD 安全性的数据,这些数据显示了真正的风险,需要考虑之前,以任何理由服用 CBD 。”该机构列出了使用 CBD 的可能风险,如肝损伤、药物相互作用,甚至可能对男性生殖健康产生负面影响。 "" 除了 CBD 本身可能带来的健康风险外, FDA 提醒消费者注意产品质量。该行业基本上不受监管。FDA 说,它已经在一些产品中测试了生物多样性公约的化学成分,发现“许多”没有包含他们说的生物多样性公约的数量。该机构还在调查含有“不安全”污染物水平的生物多样性公约的报告,如杀虫剂、重金属和 THC 。 美国食品和药物管理局周一还向15家私营 CBD 公司发出警告信,称这些公司非法将其产品做为治疗疾病的广告,销售作为膳食补充剂的产品,并将 CBD 添加到人类和动物食品中。